[68 Ga]Ga-FAPi PET/CT vs [18F]F-FDG PET/CT in various cancers: Initial experience

Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions

Watabe, Tadashi
Naka, Sadahiro
Tatsumi, Mitsuaki
Kamiya, Takashi
Kimura, Toru
Shintani, Yasushi
Abe, Kaori
Miyake, Tomohiro
Shimazu, Kenzo
Kobayashi, Shogo
Kurokawa, Yukinori
Eguchi, Hidetoshi
Doki, Yuichiro
Inohara, Hidenori
Kato, Hiroki
Mori, Yuriko
Cardinale, Jens
Giesel, Frederik L.

The 18F-labeled fibroblast activation protein inhibitor (FAPI) [18F]FAPI- 74 has the benefit of a hi...

Comparison of F-18-FLT PET and F-18-FDG PET in esophageal cancer

van Westreenen, HL
Cobben, DCP
Jager, PL
van Dullemen, HM
Wesseling, J
Elsinga, PH
Plukker, JT

March 2005

F-18-FDG PET has gained acceptance for staging of esophageal cancer. However, FDG is not tumor speci...

The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies

Yanzhao Dong
Haiying Zhou
Ahmad Alhaskawi
Zewei Wang
Jingtian Lai
Chengjun Yao
Zhenfeng Liu
Sohaib Hasan Abdullah Ezzi
Vishnu Goutham Kota
Mohamed Hasan Abdulla Hasan Abdulla
Hui Lu

February 2023

Cancer represents a major cause of death worldwide and is characterized by the uncontrolled prolifer...

Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

Giesel, Frederik L
Kratochwil, Clemens
Schlittenhardt, Joel
Dendl, Katharina
Eiber, Matthias
Staudinger, Fabian
Kessler, Lukas
Fendler, Wolfgang P
Lindner, Thomas
Koerber, Stefan A
Cardinale, Jens
Sennung, David
Roehrich, Manuel
Debus, Juergen
Sathekge, Mike
Haberkorn, Uwe
Calais, Jeremie
Serfling, Sebastian
Buck, Andreas L

December 2021

PurposeFAPI ligands (fibroblast activation protein inhibitor), a novel class of radiotracers for PET...

68Ga-FAPI-PET/CT in patients with various gynecological malignancies

Dendl, Katharina
Koerber, Stefan A.
Finck, Rebecca
Mokoala, K.M.G. (Kgomotso)
Staudinger, Fabian
Schillings, Lisa
Heger, Ulrike
Rohrich, Manuel
Kratochwil, Clemens
Sathekge, Mike Machaba
Jager, Dirk
Debus, Jurgen
Haberkorn, Uwe
Giesel, Frederik L.

November 2021

PURPOSE : 68Ga-FAPI (fibroblast activation protein inhibitor) is a novel and highly promising radiot...

Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers.

Koerber, Stefan
Röhrich, Manuel
Walkenbach, Leon
Liermann, Jakob
Choyke, Peter
Fink, Christoph
Schroeter, Cathrin
Spektor, Anna-Maria
Herfarth, Klaus
Walle, Thomas
Kauczor, Hans-Ulrich
Jaeger, Dirk
Debus, Juergen
Haberkorn, Uwe
Giesel, Frederik
Calais, Jeremie

November 2023

Since the development of fibroblast activation protein-targeted radiopharmaceuticals, 68Ga-fibroblas...

Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review

Giorgio Treglia
Barbara Muoio
Hessamoddin Roustaei
Zahra Kiamanesh
Kamran Aryana
Ramin Sadeghi

October 2021

Several recent studies comparing radiolabeled fibroblast activation protein inhibitors (FAPI) and fl...

DataSheet_1_Diagnostic value of [68Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [18F]F-FDG PET/CT.docx

Xinfeng Lin (14349405)
Yingjie Li (2106778)
Shuailiang Wang (10288124)
Yan Zhang (8098)
Xuetao Chen (12438657)
Maomao Wei (12438660)
Hua Zhu (131619)
Aiwen Wu (6339941)
Zhi Yang (124104)
Xuejuan Wang (703508)

January 2023

PurposeThis study aimed to compare the diagnostic performance of [68Ga]Ga-FAPI-04 PET/CT and [18F]F-...

Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review.

Treglia, G.
Muoio, B.
Roustaei, H.
Kiamanesh, Z.
Aryana, K.
Sadeghi, R.

October 2021

Several recent studies comparing radiolabeled fibroblast activation protein inhibitors (FAPI) and fl...

Prospective comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma

Haoyuan Ding
Haoyuan Ding
Haoyuan Ding
Haoyuan Ding
Juan Liang
Lin Qiu
Lin Qiu
Lin Qiu
Tingting Xu
Tingting Xu
Tingting Xu
Liang Cai
Liang Cai
Liang Cai
Qiang Wan
Qiang Wan
Qiang Wan
Li Wang
Li Wang
Li Wang
Ya Liu
Ya Liu
Ya Liu
Yue Chen
Yue Chen
Yue Chen
Yue Chen

December 2022

PurposeTo explore the difference in the effectiveness of gallium-68 fibroblast activation protein in...

Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions.

Glatting, Frederik M
Hoppner, Jorge
Liew, Dawn P
van Genabith, Antonia
Spektor, Anna-Maria
Steinbach, Levin
Hubert, Alexander
Kratochwil, Clemens
Giesel, Frederik L
Dendl, Katharina
Rathke, Hendrik
Kauczor, Hans-Ulrich
Huber, Peter E
Haberkorn, Uwe
Röhrich, Manuel

December 2022

68Ga-labeled fibroblast activation protein (FAP) inhibitor (68Ga-FAPI) PET targets 68Ga-FAPI-positiv...

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience

Umut Elboga
Ertan Sahin
Yusuf Burak Cayirli
Merve Okuyan
Gokmen Aktas
Handan Haydaroglu Sahin
Ilkay Dogan
Tulay Kus
Dervis Murat Akkurd
Ufuk Cimen
Vuslat Mumcu
Benan Kilbas
Yusuf Zeki Celen

February 2022

Objective: In this study, we aimed to compare [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging to detec...

Dual-Tracer PET/CT Protocol with [F-18]-FDG and [Ga-68]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept

Roth, Katrin S.
Voltin, Conrad-Amadeus
van Heek, Lutz
Wegen, Simone
Schomaecker, Klaus
Fischer, Thomas
Marnitz, Simone
Drzezga, Alexander
Kobe, Carsten

January 2022

Imaging studieswithPET tracers acting as fibroblast activation protein inhibitors (FAPIs) show promi...

FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances

Veldhuijzen van Zanten, Sophie E.M.
Pieterman, Kay J.
Wijnhoven, Bas P.L.
Pruis, Ilanah J.
Groot Koerkamp, Bas
van Driel, Lydi M.J.W.
Verburg, Frederik A.
Thomeer, Maarten G.J.

August 2022

Introduction: There is a pressing demand for the development of cancer-specific diagnostic imaging t...

Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial

Iagaru, A
Mittra, E
Mosci, C
Dick, DW
Sathekge, M
Prakash, V
Iyer, V
Lapa, P
Isidoro, J
Pedroso de Lima, JM
Gambhir, SS

February 2013

(18)F-FDG PET/CT is used in a variety of cancers, but because of variable rates of glucose metabolis...

Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions

Watabe, Tadashi
Naka, Sadahiro
Tatsumi, Mitsuaki
Kamiya, Takashi
Kimura, Toru
Shintani, Yasushi
Abe, Kaori
Miyake, Tomohiro
Shimazu, Kenzo
Kobayashi, Shogo
Kurokawa, Yukinori
Eguchi, Hidetoshi
Doki, Yuichiro
Inohara, Hidenori
Kato, Hiroki
Mori, Yuriko
Cardinale, Jens
Giesel, Frederik L.

The 18F-labeled fibroblast activation protein inhibitor (FAPI) [18F]FAPI- 74 has the benefit of a hi...

Comparison of F-18-FLT PET and F-18-FDG PET in esophageal cancer

van Westreenen, HL
Cobben, DCP
Jager, PL
van Dullemen, HM
Wesseling, J
Elsinga, PH
Plukker, JT

March 2005

F-18-FDG PET has gained acceptance for staging of esophageal cancer. However, FDG is not tumor speci...

The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies

Yanzhao Dong
Haiying Zhou
Ahmad Alhaskawi
Zewei Wang
Jingtian Lai
Chengjun Yao
Zhenfeng Liu
Sohaib Hasan Abdullah Ezzi
Vishnu Goutham Kota
Mohamed Hasan Abdulla Hasan Abdulla
Hui Lu

February 2023

Cancer represents a major cause of death worldwide and is characterized by the uncontrolled prolifer...

Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients

Giesel, Frederik L
Kratochwil, Clemens
Schlittenhardt, Joel
Dendl, Katharina
Eiber, Matthias
Staudinger, Fabian
Kessler, Lukas
Fendler, Wolfgang P
Lindner, Thomas
Koerber, Stefan A
Cardinale, Jens
Sennung, David
Roehrich, Manuel
Debus, Juergen
Sathekge, Mike
Haberkorn, Uwe
Calais, Jeremie
Serfling, Sebastian
Buck, Andreas L

December 2021

PurposeFAPI ligands (fibroblast activation protein inhibitor), a novel class of radiotracers for PET...

68Ga-FAPI-PET/CT in patients with various gynecological malignancies

Dendl, Katharina
Koerber, Stefan A.
Finck, Rebecca
Mokoala, K.M.G. (Kgomotso)
Staudinger, Fabian
Schillings, Lisa
Heger, Ulrike
Rohrich, Manuel
Kratochwil, Clemens
Sathekge, Mike Machaba
Jager, Dirk
Debus, Jurgen
Haberkorn, Uwe
Giesel, Frederik L.

November 2021

PURPOSE : 68Ga-FAPI (fibroblast activation protein inhibitor) is a novel and highly promising radiot...

Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers.

Koerber, Stefan
Röhrich, Manuel
Walkenbach, Leon
Liermann, Jakob
Choyke, Peter
Fink, Christoph
Schroeter, Cathrin
Spektor, Anna-Maria
Herfarth, Klaus
Walle, Thomas
Kauczor, Hans-Ulrich
Jaeger, Dirk
Debus, Juergen
Haberkorn, Uwe
Giesel, Frederik
Calais, Jeremie

November 2023

Since the development of fibroblast activation protein-targeted radiopharmaceuticals, 68Ga-fibroblas...

Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review

Giorgio Treglia
Barbara Muoio
Hessamoddin Roustaei
Zahra Kiamanesh
Kamran Aryana
Ramin Sadeghi

October 2021

Several recent studies comparing radiolabeled fibroblast activation protein inhibitors (FAPI) and fl...

DataSheet_1_Diagnostic value of [68Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [18F]F-FDG PET/CT.docx

Xinfeng Lin (14349405)
Yingjie Li (2106778)
Shuailiang Wang (10288124)
Yan Zhang (8098)
Xuetao Chen (12438657)
Maomao Wei (12438660)
Hua Zhu (131619)
Aiwen Wu (6339941)
Zhi Yang (124104)
Xuejuan Wang (703508)

January 2023

PurposeThis study aimed to compare the diagnostic performance of [68Ga]Ga-FAPI-04 PET/CT and [18F]F-...

Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review.

Treglia, G.
Muoio, B.
Roustaei, H.
Kiamanesh, Z.
Aryana, K.
Sadeghi, R.

October 2021

Several recent studies comparing radiolabeled fibroblast activation protein inhibitors (FAPI) and fl...

Prospective comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma

Haoyuan Ding
Haoyuan Ding
Haoyuan Ding
Haoyuan Ding
Juan Liang
Lin Qiu
Lin Qiu
Lin Qiu
Tingting Xu
Tingting Xu
Tingting Xu
Liang Cai
Liang Cai
Liang Cai
Qiang Wan
Qiang Wan
Qiang Wan
Li Wang
Li Wang
Li Wang
Ya Liu
Ya Liu
Ya Liu
Yue Chen
Yue Chen
Yue Chen
Yue Chen

December 2022

PurposeTo explore the difference in the effectiveness of gallium-68 fibroblast activation protein in...

Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions.

Glatting, Frederik M
Hoppner, Jorge
Liew, Dawn P
van Genabith, Antonia
Spektor, Anna-Maria
Steinbach, Levin
Hubert, Alexander
Kratochwil, Clemens
Giesel, Frederik L
Dendl, Katharina
Rathke, Hendrik
Kauczor, Hans-Ulrich
Huber, Peter E
Haberkorn, Uwe
Röhrich, Manuel

December 2022

68Ga-labeled fibroblast activation protein (FAP) inhibitor (68Ga-FAPI) PET targets 68Ga-FAPI-positiv...

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience

Umut Elboga
Ertan Sahin
Yusuf Burak Cayirli
Merve Okuyan
Gokmen Aktas
Handan Haydaroglu Sahin
Ilkay Dogan
Tulay Kus
Dervis Murat Akkurd
Ufuk Cimen
Vuslat Mumcu
Benan Kilbas
Yusuf Zeki Celen

February 2022

Objective: In this study, we aimed to compare [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging to detec...

Dual-Tracer PET/CT Protocol with [F-18]-FDG and [Ga-68]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept

Roth, Katrin S.
Voltin, Conrad-Amadeus
van Heek, Lutz
Wegen, Simone
Schomaecker, Klaus
Fischer, Thomas
Marnitz, Simone
Drzezga, Alexander
Kobe, Carsten

January 2022

Imaging studieswithPET tracers acting as fibroblast activation protein inhibitors (FAPIs) show promi...

FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances

Veldhuijzen van Zanten, Sophie E.M.
Pieterman, Kay J.
Wijnhoven, Bas P.L.
Pruis, Ilanah J.
Groot Koerkamp, Bas
van Driel, Lydi M.J.W.
Verburg, Frederik A.
Thomeer, Maarten G.J.

August 2022

Introduction: There is a pressing demand for the development of cancer-specific diagnostic imaging t...

Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial

Iagaru, A
Mittra, E
Mosci, C
Dick, DW
Sathekge, M
Prakash, V
Iyer, V
Lapa, P
Isidoro, J
Pedroso de Lima, JM
Gambhir, SS

February 2013

(18)F-FDG PET/CT is used in a variety of cancers, but because of variable rates of glucose metabolis...

Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions

Watabe, Tadashi
Naka, Sadahiro
Tatsumi, Mitsuaki
Kamiya, Takashi
Kimura, Toru
Shintani, Yasushi
Abe, Kaori
Miyake, Tomohiro
Shimazu, Kenzo
Kobayashi, Shogo
Kurokawa, Yukinori
Eguchi, Hidetoshi
Doki, Yuichiro
Inohara, Hidenori
Kato, Hiroki
Mori, Yuriko
Cardinale, Jens
Giesel, Frederik L.

The 18F-labeled fibroblast activation protein inhibitor (FAPI) [18F]FAPI- 74 has the benefit of a hi...

Comparison of F-18-FLT PET and F-18-FDG PET in esophageal cancer

van Westreenen, HL
Cobben, DCP
Jager, PL
van Dullemen, HM
Wesseling, J
Elsinga, PH
Plukker, JT

March 2005

F-18-FDG PET has gained acceptance for staging of esophageal cancer. However, FDG is not tumor speci...

The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies

Yanzhao Dong
Haiying Zhou
Ahmad Alhaskawi
Zewei Wang
Jingtian Lai
Chengjun Yao
Zhenfeng Liu
Sohaib Hasan Abdullah Ezzi
Vishnu Goutham Kota
Mohamed Hasan Abdulla Hasan Abdulla
Hui Lu

February 2023

Cancer represents a major cause of death worldwide and is characterized by the uncontrolled prolifer...

[68 Ga]Ga-FAPi PET/CT vs [18F]F-FDG PET/CT in various cancers: Initial experience

Abstract

Extracted data

[68 Ga]Ga-FAPi PET/CT vs [18F]F-FDG PET/CT in various cancers: Initial experience

Abstract

Extracted data

Related items

Related items